Orchestra BioMed Holdings, Inc.
Company Stats
- Market Cap
- $373.9M
- as of Sep 30, 2026
- Shares Outstanding
- 60.1M
- Free Float
- 39.8%
Income Statement
- Revenue
- $33.5M
- Operating Income
- -$51.8M
- Net Income
- -$52.7M
- EBITDA
- -$51.5M
- Revenue Growth, 3Y
- 111.6%
- FCF Margin, 3Y Avg
- -1249.8%
- FCF Margin, Worst Year
- -1927.5%
Cash Flow
- Free Cash Flow
- -$49.5M
- FCF Yield
- -13.2%
- Owner FCF Yield
- -16.4%
Balance Sheet
- Cash & Equivalents
- $34.7M
Returns & Capital
- SBC, 3Y Avg
- $10.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $33.5M | -$49.5M | -147.7% |
| FY2024 | $2.6M | -$50.8M | -1927.5% |
| FY2023 | $2.8M | -$46.2M | -1674.1% |
| FY2022 | $3.5M | -$29.9M | -845.7% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 14, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.